Gut Cells Prime Immune Attack in Multiple Sclerosis
A Keio University–led study shows intestinal epithelial cells in the ileum upregulate MHC II to prime pathogenic Th17 cells, which migrate from the gut to the CNS and drive neuroinflammation in MS; findings in mice and human biopsies suggest the gut as a therapeutic target alongside existing MS treatments.